Literature DB >> 16045460

No evidence of prolonged enterovirus excretion in HIV-seropositive patients.

Ionela Gouandjika-Vasilache1, Chantal Akoua-Koffi, Evelyne Begaud, Annick Dosseh.   

Abstract

Mutations frequently occur in oral poliovirus vaccine (OPV) strains upon replication in the human intestine. These strains occasionally revert to being neurovirulent. The more prolonged the excretion of OPV, the higher the risk of reversion. OPV strains can be secreted for several months in humans presenting humoral immune system deficiencies. The duration of excretion of OPV strains or other enteroviruses in individuals infected with the human immunodeficiency virus (HIV) is unknown. We investigated whether HIV infection, which is very prevalent in the Central African Republic, causes prolonged excretion of enteroviruses and, in particular, of OPV strains in adults. We studied 28 HIV-infected adults living with children who were immunized with OPV during national immunization days (NIDs). Blood samples were collected to confirm HIV status and to evaluate immunodeficiency before the NIDs. Stool samples for enterovirus isolation were also collected before the NIDs, between the two rounds of immunization and 2, 4 and 6 months after the second round of immunization. No poliovirus was isolated from any stool sample. Eight enteroviruses were isolated from eight adults (maximum one strain per patient). Enteroviruses were not more frequently isolated from severely immunodeficient patients. Thus, HIV-infected adults do not appear to be at high risk of infection with OPV strains and the excretion of enteroviruses (and thus of polioviruses) does not seem to be prolonged in HIV-infected adults.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16045460     DOI: 10.1111/j.1365-3156.2005.01454.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  10 in total

1.  Shedding of Oral Poliovirus Vaccine (OPV) by HIV-Infected and -Uninfected Mothers of OPV-Vaccinated Zimbabwean Infants.

Authors:  Marisa Holubar; Stephanie B Troy; Kusum Nathoo; Lynda Stranix-Chibanda; Georgina Musingwini; Nivedita Srinivas; ChunHong Huang; Alexandra Junn; Meira S Halpern; Yvonne A Maldonado
Journal:  J Pediatric Infect Dis Soc       Date:  2017-03-01       Impact factor: 3.164

2.  OPV strains circulation in HIV infected infants after National Immunisation Days in Bangui, Central African Republic.

Authors:  Alexandre Manirakiza; Emmanuella Picard; Richard Ngbale; Didier Menard; Ionela Gouandjika-Vasilache
Journal:  BMC Res Notes       Date:  2010-05-18

Review 3.  The role of prolonged viral gastrointestinal infections in the development of immunodeficiency-related enteropathy.

Authors:  Annick A J M van de Ven; David P Hoytema van Konijnenburg; Annemarie M J Wensing; Joris M van Montfrans
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

4.  NeuroAIDS in the Asia Pacific Region.

Authors:  Edwina J Wright; Michael Nunn; Jeymohan Joseph; Kevin Robertson; Luxshimi Lal; Bruce J Brew
Journal:  J Neurovirol       Date:  2008-11       Impact factor: 2.643

5.  Vaccine poliovirus shedding and immune response to oral polio vaccine in HIV-infected and -uninfected Zimbabwean infants.

Authors:  Stephanie B Troy; Georgina Musingwini; Meira S Halpern; Chunhong Huang; Lynda Stranix-Chibanda; Diana Kouiavskaia; Avinash K Shetty; Konstantin Chumakov; Kusum Nathoo; Yvonne A Maldonado
Journal:  J Infect Dis       Date:  2013-05-09       Impact factor: 5.226

Review 6.  Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part II.

Authors:  Nancy F Crum-Cianflone; Eva Sullivan
Journal:  Infect Dis Ther       Date:  2017-08-05

7.  Molecular Characterization and Clinical Description of Non-Polio Enteroviruses Detected in Stool Samples from HIV-Positive and HIV-Negative Adults in Ghana.

Authors:  Veronica Di Cristanziano; Kristina Weimer; Sindy Böttcher; Fred Stephen Sarfo; Albert Dompreh; Lucio-Garcia Cesar; Elena Knops; Eva Heger; Maike Wirtz; Rolf Kaiser; Betty Norman; Richard Odame Phillips; Torsten Feldt; Kirsten Alexandra Eberhardt
Journal:  Viruses       Date:  2020-02-16       Impact factor: 5.048

8.  Limited duration of vaccine poliovirus and other enterovirus excretion among human immunodeficiency virus infected children in Kenya.

Authors:  Nino Khetsuriani; Rita Helfand; Mark Pallansch; Olen Kew; Ashley Fowlkes; M Steven Oberste; Peter Tukei; Joseph Muli; Ernest Makokha; Howard Gary
Journal:  BMC Infect Dis       Date:  2009-08-23       Impact factor: 3.090

9.  Autologous antibody capture to enrich immunogenic viruses for viral discovery.

Authors:  Bas B Oude Munnink; Seyed Mohammad Jazaeri Farsani; Martin Deijs; Jiri Jonkers; Joost T P Verhoeven; Margareta Ieven; Herman Goossens; Menno D de Jong; Ben Berkhout; Katherine Loens; Paul Kellam; Margreet Bakker; Marta Canuti; Matthew Cotten; Lia van der Hoek
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

10.  Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodeficiency virus status: analysis from under five children.

Authors:  Joanne Hassan; Laura Wangai; Peter Borus; Christopher Khayeka-Wandabwa; Lucy Wanja Karani; Mercy Kithinji; Michael Kiptoo
Journal:  BMC Res Notes       Date:  2017-11-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.